More on OCUL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+2.6% Growth)
- Ratings (9.5 Score)
- FDA
- FDA Archive

Upcoming Events

- Earnings (8/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Ocular Therapeutix (NQ:OCUL)
Delayed: 8.97 -0.2 (2.18%)
Prev. Close $9.17  
Open$9.07 
52 Wk High$14.50 
52 Wk Low$4.04 
Day High$9.22 
Day Low$8.81 
P/E N/A  
EPS$0.00 
Volume1,880,843 

Friends, Peers and Foes (?): VRTX, ARGX, KALV, EYPT, REGN (more...)

Jul 17, 2026 05:17 AM Ocular Therapeutix (OCUL) Reiterated at Market Outperform by Citizens Ahead of Q2 Earnings
Jul 9, 2026 04:05 PM Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 1, 2026 07:00 AM Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences
Jul 1, 2026 06:19 AM William Blair Adjusts Monthly Analyst Conviction List for July 2026
Jun 22, 2026 04:05 PM Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 22, 2026 06:59 AM Ocular Therapeutix (OCUL) PT Raised to $25 at H.C. Wainwright
Jun 18, 2026 04:01 PM Form 4 OCULAR THERAPEUTIX, INC For: Jun 16 Filed by: Dugel Pravin
Jun 18, 2026 06:14 AM Ocular Therapeutix (OCUL) PT Raised to $30 at Baird
Jun 17, 2026 08:45 AM Ocular Therapeutix plans wet AMD drug filing for late 2026
Jun 17, 2026 08:45 AM Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026
View All Articles

Entities mentioned with OCUL

View All Entities